Summary: <p><a rel="nofollow" class="guestlink">Dr. Jerome Groopman</a>, Professor of Medicine at Harvard Medical School, Chief of Experimental Medicine at Beth Israel Deaconess Medical Center, and staff writer for The New Yorker, explains new approaches to Alzheimer's research for this week's Please Explain. Three decades of Alzheimer's research has brought few results in changing the course of the disease, and there have been few developments in drugs to reverse or slow cognitive decline. In his latest article, "<a rel="nofollow" target="_blank" href="http://www.newyorker.com/reporting/2013/06/24/130624fa_fact_groopman">Before Night Falls</a>," in the June 24 issue of <em>The New Yorker</em>, he looks at the potential of new studies.</p>
